October 18, 2011

Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.

August 4, 2011

Johnson & Johnson chairman and CEO Bill Weldon on Wednesday morning rang the NYSE opening bell remotely from Johnson & Johnson world headquarters here as part of the company's employee celebration of its 125th anniversary.

July 7, 2011

Johnson & Johnson on Thursday announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil, becoming the eighth and final FIFA World Cup Sponsor.

May 26, 2011

Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.

April 20, 2011

Johnson & Johnson on Tuesday announced that distribution of McNeil Consumer Healthcare consumer products will slow in the coming months as the company shifts production of its over-the-counter medicines to other manufacturing plants and implements additional third-party quality controls within those plants.

January 27, 2011

Johnson & Johnson on Tuesday postponed its plans to begin folding many of its recalled products, including several pediatric formulations, back onto retail shelves until later this fall.

January 25, 2011

Johnson & Johnson posted decreases in sales for fourth quarter 2010 and for the year, according to an earnings statement released Tuesday.

January 17, 2011

After announcing its voluntary recall of certain products at a wholesaler level on Friday, Johnson & Johnson's McNeil Consumer Healthcare division provided an update on its internal assessment phase of its comprehensive action plan.

December 15, 2010

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

December 8, 2010

Johnson & Johnson made its courtship with Dutch biotech company Crucell official by acquiring all of the company for $2.3 billion, the two companies said Wednesday.

November 22, 2010

Johnson & Johnson is recalling millions of packages of OTC drugs for allergies and pain due to manufacturing problems ...

September 16, 2010

Johnson & Johnson is set to buy up the remaining portion of Dutch biotech company...

September 16, 2010

Johnson & Johnson on Thursday reported that Colleen Goggins, worldwide chairman of the company's consumer...

September 8, 2010

Johnson & Johnson is seeking to aid the health of women and children in developing...

July 19, 2010

Johnson & Johnson on Tuesday updated its earnings guidance for full-year 2010 to $4.65 to...